SAVA Stock Analysis: Buy, Sell, or Hold?
SAVA - Cassava Sciences, Inc.
$1.99
-0.05 (-2.45%)
▼
HOLD
LOW Confidence
Last Updated: January 30, 2026
Earnings: Mar 02, 2026
29d
Get Alerted When SAVA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called SAVA this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SAVA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: SAVA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: SAVA is currently trading at $1.99, which is considered oversold relative to its 30-day fair value range of $2.02 to $2.21.
Technical Outlook: Technically, SAVA is in a downtrend. Immediate support is located at $1.93, while resistance sits at $2.33.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.00 (+292.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SAVA is in a downtrend. Immediate support is located at $1.93, while resistance sits at $2.33.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.00 (+292.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$2.02 -
$2.21
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
Protect Your Profits
Holding SAVA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 292.2% below Wall St target ($8.00)
- CAUTION: Recommendation downgraded due to -9.5% 5-day decline
Fair Price Analysis
30-Day Fair Range
$2.02 -
$2.21
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$1.93
Resistance Level
$2.34
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-1.67
Wall Street Target
$8.00
(+292.2%)
Last updated: January 30, 2026 9:44 PM ET
Data refreshes hourly during market hours. Next update: 10:44 PM
Data refreshes hourly during market hours. Next update: 10:44 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SAVA showing a specific setup today?
Insider Activity (6 Months)
4
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Robert Christopher Cook
BUY
13725 shares
2025-09-30
Richard Barry
BUY
7172 shares
2025-09-22
Richard Barry
BUY
47308 shares
2025-09-19
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 54 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$486 | 45 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$500 | 62 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$91 | 64 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$830 | 52 HOLD |
Advanced SAVA Option Strategies
Professional options setups generated by AI based on today's SAVA price and gamma walls.
